Back to Search
Start Over
Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
- Source :
-
Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2015 Mar; Vol. 20 (3), pp. 168-76. - Publication Year :
- 2015
-
Abstract
- Aim: The focus in renal transplantation is to increase long-term allograft survival. One of the limiting factors is calcineurin inhibitor (CNI)-induced fibrosis. This study attempted to examine the histological aspect of interstitial fibrosis and the modulation of the transforming growth factor-β (TGF-β) canonical signalling pathway following early withdrawal of CNI from sirolimus-based immunosuppressive therapy.<br />Methods: Forty-five kidney transplant recipients with low-medium immunologic risk were randomized and underwent protocol biopsies obtained at the time of transplantation and at 3 and 12 months thereafter. The recipients were taking tacrolimus, sirolimus and prednisone. After the 3rd month, patients were randomized into two groups: sirolimus (SRL) (removed CNI and increased sirolimus) and tacrolimus (TAC) (maintained CNI). Renal biopsies were analyzed according to Banff's 2007 criteria. The sum of Banff's ct and ci constituted the chronicity index. Fibrosis was evaluated by the histomorphometrical analysis of the total collagen and myofibroblast deposition. Immunohistochemical characterization and quantification of TGF-β, TGF-β receptor 1 (TGF-β-R1), receptor 2 (TGF-β-R2) and phospho-Smad2/3 (p-Smad2/3) were performed.<br />Results: Maintenance of CNI was associated with the increase of the surface density of collagen and α-smooth muscle actin (α-SMA), (P = 0.001). Furthermore, increased TGF-β (P = 0.02), TGF-β-R1 (P = 0.02), p-Smad2/3 (P = 0.03) and stabilized TGF-β-R2. On the other hand, the removal of CNI with increase in the dose of sirolimus limited the enhancement of the chronicity index at 12 m (SRL, 2.18 vs TAC, 3.12, P = 0.0007), diminished the deposition of fibrosis and promoted the stabilization of TGF-β, TGF-β-R2, p-Smad2/3 and myofibroblasts as well as the reduction of TGF-β-R1 (P = 0.01).<br />Conclusion: The early withdrawal of CNI limited the fibrosis progression through the stabilization of chronicity index and of the canonical TGF-β signalling pathway.<br /> (© 2014 Asian Pacific Society of Nephrology.)
- Subjects :
- Adult
Biopsy
Brazil
Calcineurin Inhibitors adverse effects
Collagen metabolism
Drug Administration Schedule
Drug Therapy, Combination
Female
Fibrosis
Graft Rejection diagnosis
Graft Rejection immunology
Graft Rejection metabolism
Graft Survival drug effects
Humans
Immunohistochemistry
Immunosuppressive Agents adverse effects
Kidney immunology
Kidney metabolism
Kidney pathology
Male
Middle Aged
Myofibroblasts drug effects
Myofibroblasts metabolism
Myofibroblasts pathology
Prospective Studies
Sirolimus adverse effects
Tacrolimus adverse effects
Time Factors
Treatment Outcome
Calcineurin Inhibitors administration & dosage
Graft Rejection prevention & control
Immunosuppressive Agents administration & dosage
Kidney drug effects
Kidney Transplantation adverse effects
Signal Transduction drug effects
Sirolimus administration & dosage
Tacrolimus administration & dosage
Transforming Growth Factor beta metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1440-1797
- Volume :
- 20
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Nephrology (Carlton, Vic.)
- Publication Type :
- Academic Journal
- Accession number :
- 25404086
- Full Text :
- https://doi.org/10.1111/nep.12368